The TRIUMPH-2 and TRIUMPH-3 studies met their primary endpoints, with results supporting retatrutide's potential use in people with obesity and associated cardiometabolic complications
In this episode, Hala and Ben will discuss: Growing up in the sticks in Northern Idaho How he defines biohacking Why the original biohackers were human cyborgs How modern science can simulate our ancestral environment How your body is like a battery Why you should go barefoot after air travel Striking the right balance between time, health, and money Why business should be your fifth priority How cold water can boost brain function When carbon dioxide can be beneficial The benefits of a deep, hypnotic trance His tips on boundless parenting Why you should teach your kids how to negotiate And other topics Ben Greenfield is a trainer, coach, speaker, podcast host, best-selling author, and a very involved parent
2026;6:1004136 DOI: Received: August 17, 2025 Accepted: November 24, 2025 Published: January 04, 2026 Academic Editor: Shile Huang, Louisiana State University Health Science Center, USA Neurodegenerative diseases, including Alzheimers, Parkinsons, Huntingtons, and Amyotrophic Lateral Sclerosis, are characterized by multifactorial pathologies that extend beyond neuronal loss to include neuroinflammation, oxidative stress, mitochondrial dysfunction, and glial dysregulation
At higher tirzepatide doses, monitoring metabolic markers becomes more important
